Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3437)
Scholar Rock Holding Corp (SRRK)
Peng Katie — Director
Shares
2,437
Price
$54.25
Total Value
$132.21K
Shares Held After
34,322
% of Holdings
6.6%
Scholar Rock Holding Corp (SRRK)
Peng Katie — Director
Shares
2,988
Price
$53.56
Total Value
$160.04K
Shares Held After
36,759
% of Holdings
7.5%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
11,430
Price
$123.58
Total Value
$1.41M
Shares Held After
85,533
% of Holdings
11.8%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,698
Price
$33.13
Total Value
$155.64K
Shares Held After
100,991
% of Holdings
4.4%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
1,834
Price
$88.34
Total Value
$162.02K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,725
Price
$88.37
Total Value
$152.44K
Shares Held After
97,994
% of Holdings
1.7%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
6,500
Price
$87.52
Total Value
$568.88K
Shares Held After
1,834
% of Holdings
78.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,775
Price
$87.55
Total Value
$505.60K
Shares Held After
99,719
% of Holdings
5.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
590
Price
$88.91
Total Value
$52.46K
Shares Held After
582,540
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
4,234
Price
$88.12
Total Value
$373.10K
Shares Held After
583,130
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
10,176
Price
$87.44
Total Value
$889.79K
Shares Held After
587,364
% of Holdings
1.7%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
4,007
Price
$37.56
Total Value
$150.50K
Shares Held After
84,645
% of Holdings
4.5%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
9,599
Price
$10.41
Total Value
$99.93K
Shares Held After
138,855
% of Holdings
6.5%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
5,500
Price
$132.74
Total Value
$730.07K
Shares Held After
177,873
% of Holdings
3.0%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
100
Price
$7.07
Total Value
$707.00
Shares Held After
86,380
% of Holdings
0.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
9,099
Price
$55.88
Total Value
$508.45K
Shares Held After
0
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
71,612
Price
$2.49
Total Value
$178.31K
Shares Held After
2,631,487
% of Holdings
2.7%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.27
Total Value
$64.05K
Shares Held After
1,169,327
% of Holdings
1.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
398
Price
$1.55
Total Value
$616.90
Shares Held After
72,988
% of Holdings
0.5%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
3,946
Price
$1.55
Total Value
$6.12K
Shares Held After
722,935
% of Holdings
0.5%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
1,233
Price
$34.81
Total Value
$42.93K
Shares Held After
96,412
% of Holdings
1.3%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
2,100
Price
$34.10
Total Value
$71.60K
Shares Held After
97,645
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
386
Price
$549.14
Total Value
$211.97K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,221
Price
$548.21
Total Value
$669.37K
Shares Held After
40,899
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
969
Price
$547.40
Total Value
$530.43K
Shares Held After
42,120
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,124
Price
$546.46
Total Value
$614.22K
Shares Held After
43,089
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$545.00
Total Value
$479.60K
Shares Held After
44,213
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$543.16
Total Value
$282.44K
Shares Held After
45,093
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$542.15
Total Value
$477.09K
Shares Held After
45,613
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
773
Price
$540.92
Total Value
$418.13K
Shares Held After
46,493
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,524
Price
$539.92
Total Value
$822.85K
Shares Held After
47,266
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
818
Price
$539.09
Total Value
$440.97K
Shares Held After
48,790
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
405
Price
$537.58
Total Value
$217.72K
Shares Held After
49,608
% of Holdings
0.8%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
739
Price
$34.06
Total Value
$25.17K
Shares Held After
92,901
% of Holdings
0.8%
GENELUX Corp (GNLX)
Smither John W — Director
Shares
12,000
Price
$2.91
Total Value
$34.90K
Shares Held After
91,403
% of Holdings
11.6%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
2,721
Price
$120.00
Total Value
$326.52K
Shares Held After
3,114
% of Holdings
46.6%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
312
Price
$71.99
Total Value
$22.46K
Shares Held After
490,312
% of Holdings
0.1%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$8.03
Total Value
$133.86K
Shares Held After
1,161,128
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,336
Price
$116.56
Total Value
$388.84K
Shares Held After
666,568
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
44,050
Price
$115.69
Total Value
$5.10M
Shares Held After
669,904
% of Holdings
6.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
24,105
Price
$114.96
Total Value
$2.77M
Shares Held After
713,954
% of Holdings
3.3%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
6,626
Price
$113.98
Total Value
$755.20K
Shares Held After
738,059
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
1,883
Price
$112.80
Total Value
$212.41K
Shares Held After
744,685
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
3,389
Price
$114.29
Total Value
$387.33K
Shares Held After
47,179
% of Holdings
6.7%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
90,000
Price
$8.03
Total Value
$722.51K
Shares Held After
1,691,126
% of Holdings
5.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
625
Price
$77.21
Total Value
$48.26K
Shares Held After
42,044
% of Holdings
1.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,000
Price
$76.39
Total Value
$76.39K
Shares Held After
42,669
% of Holdings
2.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
2,501
Price
$16.24
Total Value
$40.61K
Shares Held After
135,202
% of Holdings
1.8%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
5,852
Price
$15.67
Total Value
$91.68K
Shares Held After
137,703
% of Holdings
4.1%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$84.92
Total Value
$636.90K
Shares Held After
377,830
% of Holdings
1.9%
Showing 951–1000 of 3437 transactions (page 20 of 69)